| 000 | 01387 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512071800.0 | ||
| 264 | 0 | _c19861203 | |
| 008 | 198612s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/0024-3205(86)90159-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLotti, V J | |
| 245 | 0 | 0 |
_aA new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: comparative potencies and durations of action of nonpeptide antagonists. _h[electronic resource] |
| 260 |
_bLife sciences _cNov 1986 |
||
| 300 |
_a1631-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepinones _xpharmacology |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCholecystokinin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDevazepide |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastric Emptying _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProglumide _xadministration & dosage |
| 650 | 0 | 4 |
_aSincalide _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aCerino, D J | |
| 700 | 1 | _aKling, P J | |
| 700 | 1 | _aChange, R S | |
| 773 | 0 |
_tLife sciences _gvol. 39 _gno. 18 _gp. 1631-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(86)90159-1 _zAvailable from publisher's website |
| 999 |
_c3779340 _d3779340 |
||